Paxlovid is an oral antiviral pill to treat COVID-19 that can be taken soon after symptoms surface to help keep high-risk patients from getting so sick that they need to be hospitalized. After showing a high efficacy in clinical trials, it was granted an emergency use authorization (EUA) by the Food and Drug Administration (FDA) in December 2021.

Paxlovid is an oral antiviral pill to treat COVID-19 that can be taken soon after symptoms surface to help keep high-risk patients from getting so sick that they need to be hospitalized. After showing a high efficacy in clinical trials, it was granted an emergency use authorization (EUA) by the Food and Drug Administration (FDA) in December 2021.